Compositions and methods comprising improvements of crispr guide rnas using the h1 promoter
AssigneeThe Johns Hopkins University
InventorsVinod Jaskula-Ranga, Donald Zack, Derek Welsbie
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Johns Hopkins University
InventorsVinod Jaskula-Ranga, Donald Zack, Derek Welsbie
Estimating the term…
The presently disclosed subject matter provides compositions and methods comprising improvements of a CRISPR system (e.g. CRISPR associated (Cas) 9 (CRISPR-Cas9, non-Cas9 CRISPR systems). Such compositions may comprise modifications to the H1 promoter region, addition of 5′UTR modifications, different orthologous sequences of the H1 promoter, novel compact bidirectional promoter sequences with both pol II and pol III activity, addition of Kozak consensus sequences, termination sequences, addition of conditional pol II/pol III bidirectional promoter expression, addition of a donor template sequence for correcting mutations, or combinations thereof. Other aspects of the invention relate to modifications to Cas9 through post-transcriptional cell-cycle regulation fusions, engineered partial target sites such that the nuclease can bind without DNA cleavage, auto-regulation sites, and N-terminal modifications to modulate half-life.
A non-naturally occurring nuclease system comprising one or more vectors comprising:
The system of claim 7, wherein the adeno-associated packaging virus is adenovirus serotype 5.
The method of any one of claims 133-153, wherein the subject is a mammal.
The method of claim 154, wherein the mammal is human.
Dependencies are inferred from the claim text.